FDA.reportPublic FDA data

DESVENLAFAXINE

Substance profile for UNII NG99554ANW, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for DESVENLAFAXINE
Structure render from PubChem CID 125017

Substance Identity#

UNII
NG99554ANW
Preferred term
DESVENLAFAXINE
Registry number
93413-62-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C16H25NO2
Chemical structure for DESVENLAFAXINE
Structure render from PubChem CID 125017

Chemical And Database Identifiers#

SMILES
CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2
RxCUI
734064
PubChem
125017
NCIt
C61703
INN ID
8361

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound125017pubchem.ncbi.nlm.nih.gov/compound/125017
RxNorm734064mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=734064
NCI ThesaurusC61703ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61703
FDA Substance Registration SystemNG99554ANWprecision.fda.gov/uniisearch/srs/unii/NG99554ANW

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, oral Initial U.S. Approval: 20081
ACTIVE MOIETYPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3747
ACTIVE MOIETYPRISTIQ EXTENDED RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2068
ACTIVE MOIETYPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
ACTIVE INGREDIENTKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
ACTIVE MOIETYKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
ACTIVE INGREDIENTDESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]10
ACTIVE MOIETYDESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]10
ACTIVE MOIETYDESVENLAFAXINE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]10
ACTIVE INGREDIENTKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
ACTIVE MOIETYKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
ACTIVE MOIETYPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH]10
ACTIVE MOIETYDESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC]7
ACTIVE INGREDIENTDESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
ACTIVE MOIETYDESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
ACTIVE MOIETYPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]1